Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
21,468,878
-
Shares change
-
+2,731,824
-
Total reported value, excl. options
-
$332,291,565
-
Value change
-
+$41,921,139
-
Put/Call ratio
-
45%
-
Number of buys
-
53
-
Number of sells
-
-28
-
Price
-
$15.48
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2015
94 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q1 2015.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,468,878 shares
of 158,835,667 outstanding shares and own 14% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (3,125,149 shares), FMR LLC (3,061,070 shares), BRIDGER MANAGEMENT, LLC (2,051,821 shares), BAKER BROS. ADVISORS LP (2,050,313 shares), STATE STREET CORP (1,667,684 shares), Visium Asset Management, LP (1,301,500 shares), VANGUARD GROUP INC (1,066,992 shares), BlackRock Fund Advisors (809,701 shares), BlackRock Institutional Trust Company, N.A. (733,602 shares), and COLUMBUS CIRCLE INVESTORS (461,399 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.